Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 43, 2024 - Issue 1
104
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Histopathologic alterations in the eyelid after Hughes tarsoconjunctival flap: loss of Meibomian glands with preservation of accessory lacrimal glands

, &
Pages 115-118 | Received 22 Dec 2021, Accepted 02 May 2022, Published online: 26 May 2022

References

  • Wang MT, Kersey TL, Sloan BH, Craig JP. Evaporative dry eye following modified Hughes flap reconstruction. Clin Exp Ophthalmol. 2018;46:700–702.
  • Klein-Theyer A, Horwath-Winter J, Dieter FR, Haller-Schober EM, Riedl R, Boldin I. Evaluation of ocular surface and tear film function following modified Hughes tarsoconjunctival flap procedure. Acta Ophthalmol. 2014;92:286–290.
  • Tenland K, Memarzadeh K, Berggren J, et al. Perfusion monitoring shows minimal blood flow from the flap pedicle to the tarsoconjunctival flap. Ophthalmic Plast Reconstr Surg. 2019;35(4):346–349.
  • Kim JA, Lee YJ, Jang SY. Meibomian gland dysfunction in patients who underwent transconjunctival approach surgery for inferior orbital wall fractures. J Craniofac Surg. 2019;30:1891–1893.
  • Toshida H, Ohta T, Suto C, Murakami A. Effect of subconjunctival lacrimal gland transplantation in a rabbit dry eye model. Cornea. 2013;32:S46–51.
  • Buckman G, Jakobiec FA, Hyde K, Lisman RD, Hornblass A, Harrison W. Success of the Fasanella-Servat operation independent of Müller’s smooth muscle excision. Ophthalmology. 1989;96:413–418.
  • Golan S, Vingopoulos F, Olson LC, et al. Lacrimal tissue resection in Fasanella Servat operation and the correlation to dry eye. Orbit. 2020;39(3):171–174. doi:10.1080/01676830.2019.1649435.
  • Pang NK, Newsom RW, Oestreicher JH, Chung HT, Harvey JT. Fasanella-Servat procedure: indications, efficacy, and complications. Can J Ophthalmol. 2008;43:84–88.
  • Lo C, Petris C, Lisman R. Transient dry eye following the Fasanella-Servat operation in the early postoperative period. Invest Ophthalmol Vis Sci. 2016;57(12): 676-.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.